The most effective way to decide is to consult with a dedicated weight loss specialist who can review your health profile and outline a customized plan
For most long-acting GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), and tirzepatide (Mounjaro, Zepbound), the answer is nofood timing doesn't matter
When GLP-1 binds to its receptor, it amplifies the insulin signaling pathway, causing increased phosphorylation of insulin receptor substrates and activating the PI3K/Akt pathway, which ultimately results in enhanced glucose uptake, utilization within the liver, and reduced production of glucose (gluconeogenesis)
(To allay those concerns, some companies post lab results attesting to the purity of their products.) Of course, everybody thinks their dealer is an exception
In those cases, addressing estrogen and other hormones more directly may be necessary